Moneycontrol PRO

business

Brought GSK board to see India's potential: CEO Witty

GlaxoSmithKline CEO Andrew Witty believes its Indian business will grow despite challenges in the Indian pharma sector

first published: Oct 18, 2012 08:30 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347